comparemela.com
  1. Home
  2. Live Updates
  3. Sales In Core Laboratory - Breaking News

Sales In Core Laboratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022. Second-quarter sales of $11.3 billion.

Robertb fordDrug administrationCore laboratory diagnosticsSales in core laboratoryEuropean union medical deviceAbbott laboratoriesCore laboratoryPediatric nutritionAdult nutritionMolecular diagnosticsEmerging marketsMedical devicesDiabetes careFreestyle libreAristocrats indexInvestor relations

Abbott Reports First-Quarter 2022 Results

/PRNewswire/ Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2022..

Robertb fordDrug administrationCore laboratory diagnosticsSales in core laboratoryEuropean union medical deviceAbbott laboratoriesCore laboratoryMedical devicesEstablished pharmaceuticalsAdult nutritionPediatric nutritionMolecular diagnosticsEmerging marketsHeart failureStructural heartDiabetes care

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.